Boswellia carteri Birdwod


  • Ammon HP, et al. (1991) Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med.; 57(3): 203-7.
  • Ammon HP, et al. Mechanism of anti-inflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 1993 Mar; 38(2-3): 113-9.
  • Ammon HP. Salai Guggal - Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis. Eur J Med Res. 1996 May 24; 1(8): 369-70.
  • Duwiejua M, et al. Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Med. 1993 Feb; 59(1): 12-6.
  • Gupta I, et al. (1998) Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 17; 3(11): 511-4.
  • Gupta I, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997 Jan; 2(1): 37-43.
  • Jing Y, et al. (1992) Growth inhibition and differentiation of promyelocytic cells (HL-60) induced by BC-4, an active principle from Boswellia carterii Birdw. Med Sci J.; 7(1): 12-5.
  • Jing Y, et al. (1999) Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk Res.; 23(1): 43-50.
  • Jing YK, et al. (1993) Combination induction of cell differentiation of HL-60 cells by daidzein (S86019) and BC-4 or Ara-C. Yao Hsueh Hsueh Pao.; 28(1): 11-6. .
  • Kapil A, et al. (1992) Anticomplementary activity of boswellic acids, an inhibitor of C3-convertase of the classical complement pathway. J Immunopharmacol; 14(7): 1139-43.
  • Kar A, et al. (1969) Analgesic effect of the gum resin of Boswellia serrata Roxb. Life Sci. 1; 8(19): 1023-8
  • Kulkarni RR, et al. (1991) Treatment of osteoarthritis with a herbomineral formulation: a double blind, placebo-controlled, crossover study. J Ethnopharmacol.; 33(1-2): 91-5.
  • Menon MK, et al. (1971) Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med.; 19(4): 333-41.
  • Reddy GK, et al. (1989) Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem Pharmacol. 15; 38(20): 3527-34.
  • Safayhi H, et al. (1992) Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther.; 261(3): 1143-6.
  • Safayhi H, et al.(1991) Protection by boswellic acids against galactosamine/endotoxin induced hepatitis in mice. Biochem. Pharmacol. 41: 1536-1537.
  • Sander O, et al. Is H15 (resin extract of Boswellia serrata, ""incense"") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double blind pilot study. Rheumatol. 1998 Feb; 57(1): 11-6.
  • Shao Y, et al. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med. 1998 May; 64(4): 328-31.
  • Sharma ML, et al. (1988) Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leukocyte migration. Agents Actions; 24(1-2): 161-4.
  • Singh et al. (1987) Open and double blind studies on anti-arthritic effect of boswellic acids. Abstract presented at international conference on clinical pharmacology and therapeutics held at Bombay (India), 20-22 Nov, FPS 8/5.
  • Singh GB, et al. (1992) Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 44; 456-458.
  • Singh GB, et al. (1986) Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions. 18(3-4): 407-12.
  • Singh GB, et al. (1993) Boswellic acids anti-inflammatory, anti-arthritic and anti-pyretic. Drugs of Future. 18: 307-309
  • Wildfeuer A, et al. (1998) Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung. 48(6): 668-74.